Daratumumab (anti-CD38) [945721-28-8]
A2027
Product group Chemicals
Overview
- SupplierSelleck Chemicals
- Product NameDaratumumab (anti-CD38) [945721-28-8]
- Delivery Days Customer9
- CertificationResearch Use Only
- Scientific DescriptionDaratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.
- UNSPSC12352200